Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE DU CHARDON : revenue, balance sheet and financial ratios

PHARMACIE DU CHARDON is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in BOUSSE (57310), this company of category PME shows in 2015 a revenue of 1.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE DU CHARDON (SIREN 523078947)
Indicator 2021 2019 2018 2017 2016 2015
Revenue N/C N/C N/C N/C N/C 1 434 481 €
Net income 139 955 € 186 530 € 107 841 € 128 412 € 123 392 € 131 660 €
EBITDA N/C N/C N/C N/C N/C 208 839 €
Net margin N/C N/C N/C N/C N/C 9.2%

Revenue and income statement

In 2021, PHARMACIE DU CHARDON generates positive net income of 140 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2021: 132 k€ -> 140 k€.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

139 955 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 30%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 69%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

30.221%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

68.622%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

30.1%

Solvency indicators evolution
PHARMACIE DU CHARDON

Sector positioning

Debt ratio
30.22 2021
2018
2019
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Good -19 pts over 3 years

In 2021, the debt ratio of PHARMACIE DU CHARDON (30.22) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
68.62% 2021
2018
2019
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Excellent +18 pts over 3 years

In 2021, the financial autonomy of PHARMACIE DU CHARDON (68.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 333.91. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

333.908

Liquidity indicators evolution
PHARMACIE DU CHARDON

Sector positioning

Liquidity ratio
333.91 2021
2018
2019
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Excellent +26 pts over 3 years

In 2021, the liquidity ratio of PHARMACIE DU CHARDON (333.91) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE DU CHARDON

Positioning of PHARMACIE DU CHARDON in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of PHARMACIE DU CHARDON is estimated at 1 605 342 € (range 1 032 242€ - 2 479 749€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
1032k€ 1605k€ 2479k€
1 605 342 € Range: 1 032 242€ - 2 479 749€
NAF 5 année 2021

Valuation method used

Net Income Multiple
139 955 € × 11.5x = 1 605 342 €
Range: 1 032 243€ - 2 479 749€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE DU CHARDON with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE DU CHARDON

What is the revenue of PHARMACIE DU CHARDON ?

The revenue of PHARMACIE DU CHARDON in 2015 is 1.4 M€.

Is PHARMACIE DU CHARDON profitable?

Yes, PHARMACIE DU CHARDON generated a net profit of 140 k€ in 2021.

Where is the headquarters of PHARMACIE DU CHARDON ?

The headquarters of PHARMACIE DU CHARDON is located in BOUSSE (57310), in the department Moselle.

Where to find the tax return of PHARMACIE DU CHARDON ?

The tax return of PHARMACIE DU CHARDON is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE DU CHARDON operate?

PHARMACIE DU CHARDON operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.